Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products > 33125 > 

33125-97-2

Products Categories

Basic Information
CAS No.: 33125-97-2
Name: Etomidate
Article Data: 4
Molecular Structure:
Molecular Structure of 33125-97-2 (Etomidate)
Formula: C14H16N2O2
Molecular Weight: 244.293
Synonyms: Hypnomidate;Propiscin;R 16659;Radenarcon;1H-Imidazole-5-carboxylicacid, 1-(1-phenylethyl)-, ethyl ester, (R)-;Imidazole-5-carboxylic acid, 1-(a-methylbenzyl)-, ethyl ester,(R)-(+)- (8CI);Amidate;D-Etomidate;
EINECS: 251-385-9
Density: 1.118 g/cm3
Melting Point: 72-74 °C
Boiling Point: 391.485 °C at 760 mmHg
Flash Point: 190.563 °C
Appearance: Colourless solid
Hazard Symbols: HarmfulXn
Risk Codes: 22
Safety: 36
PSA: 44.12000
LogP: 2.66910
Synthetic route
64-17-5

ethanol

1-[(1R)-1-phenylethyl]-5-hydroxymethylimidazole

33125-97-2

etomidate

Conditions
ConditionsYield
With sodium cyanide; manganese(IV) oxide; acetic acid at 80℃; for 12h;85%
1445-91-6

(S)-1-phenylethanol

23785-21-9

1H-imidazole-5-carboxylic acid ethyl ester

33125-97-2

etomidate

Conditions
ConditionsYield
With di-tert-butyl-diazodicarboxylate; triphenylphosphine In tetrahydrofuran at -40℃; Mitsunobu reaction; Inert atmosphere;70%
97849-55-3

[1-11C]ethyl iodide

56649-48-0

(R)-(+)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid

33125-97-2

etomidate

Conditions
ConditionsYield
With tetra(n-butyl)ammonium hydroxide In N,N-dimethyl-formamide at 120℃; for 0.0833333h;

[Ru(2,2′-bipyridine)2(etomidate)2](PF6)2

A

[Ru(2,2′-bipyridine)2(etomidate)(H2O)](PF6)2

B

33125-97-2

etomidate

Conditions
ConditionsYield
for 0.0166667h; Kinetics; Time; UV-irradiation;

[Ru(2,2′-bipyridine)2(etomidate)2]Cl2

75-05-8

acetonitrile

A

55124-54-4

bis(acetonitrile)bis(2,2'-bipyridine)ruthenium(II) hexafluorophosphate

B

33125-97-2

etomidate

Conditions
ConditionsYield
for 1h; Kinetics; Time; UV-irradiation;

C12H14N2OS

33125-97-2

etomidate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: acetic acid; sodium nitrite / tetrahydrofuran; water / 0.5 h / Flow reactor
2: manganese(IV) oxide; sodium cyanide; acetic acid / 12 h / 80 °C
View Scheme
33125-97-2

etomidate

56649-48-0

(R)-(+)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid

Conditions
ConditionsYield
With methanol; lithium hydroxide In tetrahydrofuran; water at 20℃;93%
With sodium hydroxide In methanol at 20℃; for 6h;91.5%
With methanol; sodium hydroxide at 20℃; for 6h;90.1%
67-63-0

isopropyl alcohol

33125-97-2

etomidate

771422-77-6

C15H18N2O2

Conditions
ConditionsYield
With sodium isopropylate at 20℃; for 5h;80%
71-23-8

propan-1-ol

33125-97-2

etomidate

61045-93-0

C15H18N2O2

Conditions
ConditionsYield
With sodium n-propoxide at 20℃; for 5h;78%
67-56-1

methanol

33125-97-2

etomidate

61045-91-8

(R)-Metomidate

Conditions
ConditionsYield
With sodium methylate at 20℃; for 5h;71%
  • Display:default sort

    New supplier

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

Specification

The Etomidate, with the CAS registry number 33125-97-2, is also known as Imidazole-5-carboxylic acid, 1-(α-methylbenzyl)-, ethyl ester, (R)-(+)-. It belongs to the product categories of Chiral; Aromatics Compounds; Aromatics; Heterocycles; Intermediates & Fine Chemicals; Pharmaceuticals; GABA/Glycine receptor; GABA. Its EINECS registry number is 251-385-9. This chemical's molecular formula is C14H16N2O2 and molecular weight is 244.29. What's more, its systematic name is called Ethyl 1-[(1R)-1-phenylethyl]-1H-imidazole-5-carboxylate. Etomidate is a short acting intravenous anaesthetic agent used for the induction of general anaesthesia and for sedation for short procedures such as reduction of dislocated joints, tracheal intubation and cardioversion.

Physical properties about Etomidate are: (1)ACD/LogP: 3.256; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 3.23; (4)ACD/LogD (pH 7.4): 3.26; (5)ACD/BCF (pH 5.5): 166.82; (6)ACD/BCF (pH 7.4): 175.63; (7)ACD/KOC (pH 5.5): 1336.15; (8)ACD/KOC (pH 7.4): 1406.70; (9)#H bond acceptors: 4; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 5; (12)Polar Surface Area: 44.12 Å2; (13)Index of Refraction: 1.561; (14)Molar Refractivity: 70.848 cm3; (15)Molar Volume: 218.528 cm3; (16)Polarizability: 28.086×10-24cm3; (17)Surface Tension: 39.829 dyne/cm; (18)Density: 1.118 g/cm3; (19)Flash Point: 190.563 °C; (20)Enthalpy of Vaporization: 64.11 kJ/mol; (21)Boiling Point: 391.485 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25 °C.

When you are dealing with this chemical, you should be very careful. This chemical may cause damage to health and it is harmful if swallowed. Therefore, you should wear suitable protective clothing.

You can still convert the following datas into molecular structure:
(1) SMILES: O=C(OCC)c1cncn1[C@@H](c2ccccc2)C
(2) InChI: InChI=1S/C14H16N2O2/c1-3-18-14(17)13-9-15-10-16(13)11(2)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3/t11-/m1/s1
(3) InChIKey: NPUKDXXFDDZOKR-LLVKDONJSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
human TDLo intravenous 300ug/kg (.3mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Anesthesia and Analgesia Vol. 55, Pg. 730, 1976.
man TDLo intravenous 3977ug/kg/3H- (3.977mg/kg) BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) Anesthesia and Analgesia Vol. 64, Pg. 80, 1985.
mouse LD50 intravenous 29500ug/kg (29.5mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ATAXIA
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 214, Pg. 92, 1975.
mouse LD50 oral 650mg/kg (650mg/kg)   Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65(1), Pg. 19S, 1969.
rat LD50 intravenous 14800ug/kg (14.8mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Archives Internationales de Pharmacodynamie et de Therapie. Vol. 214, Pg. 92, 1975.